- Home
- IMVT vs NSP Comparison
IMVT vs NSP Comparison
Compare IMVT & NSP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- IMVT
- NSP
- Stock Information
- Founded
- IMVT 2018
- NSP 1986
- Country
- IMVT United States
- NSP United States
- Employees
- IMVT N/A
- NSP N/A
- Industry
- IMVT Biotechnology: Biological Products (No Diagnostic Substances)
- NSP Professional Services
- Sector
- IMVT Health Care
- NSP Consumer Discretionary
- Exchange
- IMVT Nasdaq
- NSP Nasdaq
- Market Cap
- IMVT 2.8B
- NSP 2.4B
- IPO Year
- IMVT N/A
- NSP 1997
- Fundamental
- Price
- IMVT $15.80
- NSP $59.59
- Analyst Decision
- IMVT Buy
- NSP Hold
- Analyst Count
- IMVT 10
- NSP 3
- Target Price
- IMVT $40.14
- NSP $80.00
- AVG Volume (30 Days)
- IMVT 1.3M
- NSP 464.5K
- Earning Date
- IMVT 08-05-2025
- NSP 07-31-2025
- Dividend Yield
- IMVT N/A
- NSP 3.98%
- EPS Growth
- IMVT N/A
- NSP N/A
- EPS
- IMVT N/A
- NSP 1.65
- Revenue
- IMVT N/A
- NSP $6,642,000,000.00
- Revenue This Year
- IMVT N/A
- NSP $4.83
- Revenue Next Year
- IMVT N/A
- NSP $5.99
- P/E Ratio
- IMVT N/A
- NSP $36.55
- Revenue Growth
- IMVT N/A
- NSP 1.90
- 52 Week Low
- IMVT $12.72
- NSP $59.09
- 52 Week High
- IMVT $34.47
- NSP $104.90
- Technical
- Relative Strength Index (RSI)
- IMVT 53.39
- NSP 24.14
- Support Level
- IMVT $15.11
- NSP $59.76
- Resistance Level
- IMVT $17.08
- NSP $61.89
- Average True Range (ATR)
- IMVT 0.76
- NSP 1.65
- MACD
- IMVT -0.00
- NSP 0.06
- Stochastic Oscillator
- IMVT 47.56
- NSP 9.19
About IMVT Immunovant Inc.
Immunovant Inc is a clinical-stage immunology company dedicated to enabling normal lives for people with autoimmune diseases. Its focus is on developing IMVT-1402, a potential inhibitor of the neonatal fragment crystallizable receptor (FcRn), to address autoimmune diseases driven by high levels of pathogenic immunoglobulin G (IgG) antibodies. FcRn is involved in preventing the degradation of IgG antibodies, and inhibition of FcRn has been shown to reduce levels of total IgG and pathogenic IgG antibodies. The company operates in a single operating segment, which includes all activities related to the research, development and manufacturing of its product candidates.
About NSP Insperity Inc.
Insperity Inc is a company that provides a wide range of human resources and business solutions designed to help businesses improve their performance. Small and midsize enterprises are the company's primary target customers. Majority of the company's products are offered through the company's Workforce Optimization and Workforce Synchronization solutions, which comprise various human resource functions, such as payroll and employment administration, employee benefits and compensation, government compliance, performance management, training and development services, and human capital management. The company generates all of its revenue in the United States.